News
PCI Pharma Services Successfully Completes International Inspection of New Hampshire Campus
PCI Pharma Services, a Philadelphia-based contract development and manufacturing organization (CDMO), announced in a press release on Aug. 21, 2024 that its Bedford, NH campus successfully completed the multi-agency inspection process of the International Coalition of Medicines Regulatory Authorities...
Drug Research
FUJIFILM Diosynth Biotechnologies Celebrates Opening of Billingham, UK Microbial Manufacturing Facility
FUJIFILM Diosynth Biotechnologies, a world leading contract development and manufacturing organization (CDMO) for biologics, vaccines, advanced therapies, and oncolytic viruses hosted a celebration for the opening of its microbial fermentation manufacturing facility in Billingham. This new facility triples existing...
News
Touchlight, University of Nottingham Partner to Develop Zika DNA Vaccine
Scientists at the University of Nottingham are scaling up the development of a new Zika virus DNA vaccine thanks to a collaboration with specialist company, Touchlight, who will provide new technology to to produce large quantities of the DNA...
News
RedHill announces launch of Talicia in UAE to treat bacterial infection
RedHill Biopharma Ltd. , a specialty biopharmaceutical company announced the launch of Talicia (omeprazole magnesium, amoxicillin and rifabutin) in the United Arab Emirates (UAE) – making it available by prescription to treat adults with Helicobacter pylori (H. pylori) infection....
News
The Role of Gut-Brain Connection in Dental Health: A New Perspective on Patient Care
The intricate relationships within our bodies often reveal surprising connections that can redefine how we approach healthcare. One such relationship is the one between the gut, the brain, and the mouth. The gut-brain connection not only maintains mental and...
Drug Research
Hoth Therapeutics and Aronnax Inc. Enter Master Services Agreement For HT-KIT Cancer Therapeutic
Hoth Therapeutics, Inc., a patient-focused biopharmaceutical company, announced that it has entered into a Master Services Agreement with Aronnax, Inc. for its HT-KIT cancer therapeutic.
HT-KIT research, which was conducted at NC State University to evaluate the efficacy of HT-KIT...
News
Crown Laboratories and Revance Announce Entry Into Merger Agreement
Crown Laboratories, Inc., a privately held, global innovative leader in the skincare industry, and Revance Therapeutics, Inc., a biotechnology company aimed at setting the new standard in healthcare with innovative aesthetic and therapeutic offerings, today announced that they have...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read